Qureight Closes $20 million Series B Financing
- Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension
- Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to further accelerate clinical trials in lung fibrosis
- Building a state of the art AI imaging laboratory will allow Qureight to move rapidly into new lung and heart diseases including asthma, pulmonary hypertension and bronchiectasis